Author

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Author Report for: Shang J

No contact information in database for Shang J




    Title: Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
    Wan Y, Shang J, Sun S, Tai W, Chen J, Geng Q, He L, Chen Y, Wu J and Li F <3 more author(s)>
    Ref: J Virol, 94:, 2020 : PubMed

            

    Title: A molecular approach to rationally constructing specific fluorogenic substrates for the detection of acetylcholinesterase activity in live cells, mice brains and tissues
    Wu X, An JM, Shang J, Huh E, Qi S, Lee E, Li H, Kim G, Ma H and Yoon J <2 more author(s)>
    Ref: Chem Sci, 11:11285, 2020 : PubMed

            

    Title: Shen-Yuan-Dan Capsule Attenuates Atherosclerosis and Foam Cell Formation by Enhancing Autophagy and Inhibiting the PI3K/Akt/mTORC1 Signaling Pathway
    Zhou M, Ren P, Zhang Y, Li S, Li M, Li P, Shang J, Liu W, Liu H
    Ref: Front Pharmacol, 10:603, 2019 : PubMed

            

    Title: A Novel Egr-1-Agrin Pathway and Potential Implications for Regulation of Synaptic Physiology and Homeostasis at the Neuromuscular Junction
    MacDonald R, Barbat-Artigas S, Cho C, Peng H, Shang J, Moustaine A, Carbonetto S, Robitaille R, Chalifour LE, Paudel H
    Ref: Front Aging Neurosci, 9:258, 2017 : PubMed

            

    Title: Design, synthesis, biological evaluation, and molecular modeling studies of chalcone-rivastigmine hybrids as cholinesterase inhibitors
    Wang L, Wang Y, Tian Y, Shang J, Sun X, Chen H, Wang H, Tan W
    Ref: Bioorganic & Medicinal Chemistry, 25:360, 2017 : PubMed

            

    Title: Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model
    Zhai Y, Yamashita T, Nakano Y, Sun Z, Shang J, Feng T, Morihara R, Fukui Y, Ohta Y and Abe K <1 more author(s)>
    Ref: J Alzheimers Dis, 53:893, 2016 : PubMed

            

    Title: Strategies for integral metabolism profile of multiple compounds in herbal medicines: pharmacokinetics, metabolites characterization and metabolic interactions
    Xin GZ, Qi LW, Shi ZQ, Li P, Hao HP, Wang GJ, Shang J
    Ref: Curr Drug Metab, 12:809, 2011 : PubMed

            

    Title: Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors
    Edmondson SD, Wei L, Xu J, Shang J, Xu S, Pang J, Chaudhary A, Dean DC, He H and Weber AE <8 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 18:2409, 2008 : PubMed

            

    Title: (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]tr iazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Edmondson SD, Mastracchio A, Mathvink RJ, He J, Harper B, Park YJ, Beconi M, Di Salvo J, Eiermann GJ and Weber AE <16 more author(s)>
    Ref: Journal of Medicinal Chemistry, 49:3614, 2006 : PubMed

            


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer